1. Home
  2. GSUN vs CMND Comparison

GSUN vs CMND Comparison

Compare GSUN & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GSUN

Golden Sun Education Group Limited

N/A

Current Price

$0.23

Market Cap

2.7M

Sector

Real Estate

ML Signal

N/A

Logo Clearmind Medicine Inc.

CMND

Clearmind Medicine Inc.

N/A

Current Price

$0.97

Market Cap

2.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GSUN
CMND
Founded
1997
2017
Country
China
Canada
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7M
2.6M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
GSUN
CMND
Price
$0.23
$0.97
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.4M
297.0K
Earning Date
02-13-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.17
$0.07
52 Week High
$3.31
$4.66

Technical Indicators

Market Signals
Indicator
GSUN
CMND
Relative Strength Index (RSI) 40.83 26.47
Support Level $0.17 $0.59
Resistance Level $0.55 $1.27
Average True Range (ATR) 0.07 0.15
MACD -0.01 -0.09
Stochastic Oscillator 5.12 5.23

Price Performance

Historical Comparison
GSUN
CMND

About GSUN Golden Sun Education Group Limited

Golden Sun Technology Group Ltd operates two principal lines of business: tutorial services and e-commerce services. The company's e-commerce operations currently consist of data analytics-driven marketing and social media promotional services for small and medium-sized businesses on short video platforms based in China. The company's education centers offer two main programs, comprising of foreign language tutorial programs in less commonly taught languages, including, among other things, Spanish and Japanese, provided to individual students as well as to companies and other organizations; and Gaokao repeater tutorial programs, provided to individual students.

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.

Share on Social Networks: